The proposed multi-epitope vaccine shows promising immunological and structural properties, supporting its potential against S. typhimurium, pending experimental validation.
Abstract
Salmonella typhimurium
is a major foodborne pathogen with increasing multidrug resistance and limited vaccine options. This study aimed to design a multi-epitope vaccine targeting the
PstS
protein using an immunoinformatics approach. B-cell and T-cell epitopes were predicted, screened, and assembled into a chimeric construct with an adjuvant and linkers. The vaccine was evaluated for physicochemical properties, structural stability, and population coverage. Molecular docking with TLR4 and 100 ns molecular dynamics simulations were performed, followed by in silico immune simulation and codon optimization. The designed construct showed high antigenicity, stability, and hydrophilicity with broad population coverage (> 97%). Structural validation confirmed a stable fold. Docking demonstrated strong binding to TLR4, which remained stable during molecular dynamics simulations. Immune simulation predicted robust antibody and T-cell responses with a dominant Th1-type profile. The proposed multi-epitope vaccine shows promising immunological and structural properties, supporting its potential against
S. typhimurium
, pending experimental validation.
The results highlight the potential of the proposed multi-epitope construct as a promising vaccine candidate against HCMV, however, experimental validation is essential to confirm its immunogenicity, safety, and translational applicability.
O. P. Emmanuel, M. N. Y. Sandrine, Bilanda Danielle Claude et al.· Scientific Reports· 0 citations
The designed HA-based multi-epitope vaccine demonstrated promising immunogenicity, safety, structural stability, and broad population coverage in silico, and its potential as a vaccine candidate against Influenza A (H1N1) is supported.
Roshni Khan, Salman Khan· INTERNATIONAL JOURNAL OF APP...· 0 citations
This study presents a structurally optimized and validated multiepitope vaccine candidate against the emerging Batai orthobunyavirus, identifying a promising vaccine candidate for further investigation; however, its immunogenicity, safety, and protective efficacy before further vaccine development can be considered.
M. A. Alwaili, N. Al‐Hoshani, Huda A Alqahtani et al.· Pharmaceuticals· 0 citations
The two proposed multi-epitope mRNA vaccine constructs showed promising immunogenic, safety, and structural properties in silico, highlighting their potential as candidate vaccines against HMPV.
E. K. Oladipo, James Akinwumi Ogunniran, Oluwaseyi Samuel Akinpelu et al.· Discover Immunity· 1 citation
A computationally validated multi-epitope peptide vaccine construct with strong immunogenicity were generated, but validation through the in-vitro and in-vivo study of the developed vaccine is essential to assess its efficacy and immunogenicity profile.
A. T. Gessese, M. Kinde, Tegegne Eshetu et al.· Scientific Reports· 0 citations
A new machine-learning framework aims to improve the success rate of computational protein design while moving away from results that reproduce sequences found in nature.